FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311598033> ?p ?o ?g. }

• W4311598033 endingPage "e005769" @default.
• W4311598033 startingPage "e005769" @default.
• W4311598033 abstract "Background Myeloid‐derived suppressor cells (MDSCs) can potently inhibit T-cell activity, promote growth and metastasis of tumor and contribute to resistance to immunotherapy. Targeting MDSCs to alleviate their protumor functions and immunosuppressive activities is intimately associated with cancer immunotherapy. Natural killer (NK) cells can engage in crosstalk with multiple myeloid cells to alter adaptive immune responses, triggering T-cell immunity. However, whether the NK-cell-MDSC interaction can modulate the T-cell immune response requires further study. Cryo-thermal therapy could induce the maturation of MDSCs by creating an acute inflammatory environment to elicit a CD4 + Th1-dominant immune response, but the mechanism regulating this process remains unclear. Methods NK cells were depleted and NKG2D was blocked with monoclonal antibodies in vivo. MDSCs, NK cells and T cells were assessed by flow cytometry and isolated by magnetic-activated cell sorting (MACS). MDSCs and NK cells were cocultured with T cells to determine their immunological function. The transcriptional profiles of MDSCs were measured by qRT-PCR and RNA-sequencing. Isolated NK cells and MDSCs by MACS were cocultured to study the viability and maturation of MDSCs regulated by NK cells. TIMER was used to comprehensively examine the immunological, clinical, and genomic features of tumors. Results NK-cell activation after cryo-thermal therapy decreased MDSC accumulation and reprogrammed immunosuppressive MDSCs toward a mature phenotype to promote T cell antitumor immunity. Furthermore, we discovered that NK cells could kill MDSCs via the NKG2D-NKG2DL axis and promote MDSC maturation by interferon gamma (IFN-γ) in response to NKG2D. In addition, CD4 + Th1-dominant antitumor immune response was dependent on NKG2D, which promoted the major histocompatibility complex Ⅱ pathway of MDSCs. High activated NK-cell infiltration and NKG2D level in tumors were positively correlated with better clinical outcomes. Conclusions Cryo-thermal therapy induces effective CD4 + Th1-dominant antitumor immunity by activating NK cells to reprogram MDSCs, providing a promising therapeutic strategy for cancer immunotherapy." @default.
• W4311598033 created "2022-12-27" @default.
• W4311598033 creator A5001994677 @default.
• W4311598033 creator A5003952746 @default.
• W4311598033 creator A5014284237 @default.
• W4311598033 creator A5023853520 @default.
• W4311598033 creator A5023930172 @default.
• W4311598033 creator A5043622943 @default.
• W4311598033 creator A5043634025 @default.
• W4311598033 creator A5051567139 @default.
• W4311598033 creator A5077153113 @default.
• W4311598033 date "2022-12-01" @default.
• W4311598033 modified "2023-10-18" @default.
• W4311598033 title "Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy" @default.
• W4311598033 cites W1487837095 @default.
• W4311598033 cites W1489515520 @default.
• W4311598033 cites W1964572598 @default.
• W4311598033 cites W2004150448 @default.
• W4311598033 cites W2008771266 @default.
• W4311598033 cites W2013107562 @default.
• W4311598033 cites W2014135188 @default.
• W4311598033 cites W2051657147 @default.
• W4311598033 cites W2084848633 @default.
• W4311598033 cites W2087569038 @default.
• W4311598033 cites W2113403004 @default.
• W4311598033 cites W2128629902 @default.
• W4311598033 cites W2146313292 @default.
• W4311598033 cites W2153503451 @default.
• W4311598033 cites W2158853057 @default.
• W4311598033 cites W2169876627 @default.
• W4311598033 cites W2264085200 @default.
• W4311598033 cites W2266683146 @default.
• W4311598033 cites W2425974003 @default.
• W4311598033 cites W2461810891 @default.
• W4311598033 cites W2597753903 @default.
• W4311598033 cites W2616497407 @default.
• W4311598033 cites W2766706536 @default.
• W4311598033 cites W2801148264 @default.
• W4311598033 cites W2801651436 @default.
• W4311598033 cites W2803369586 @default.
• W4311598033 cites W2884754721 @default.
• W4311598033 cites W2885605094 @default.
• W4311598033 cites W2910109098 @default.
• W4311598033 cites W2919245314 @default.
• W4311598033 cites W2924696037 @default.
• W4311598033 cites W2952598829 @default.
• W4311598033 cites W2994621349 @default.
• W4311598033 cites W2998493318 @default.
• W4311598033 cites W3000339487 @default.
• W4311598033 cites W3027286012 @default.
• W4311598033 cites W3028523516 @default.
• W4311598033 cites W3037919768 @default.
• W4311598033 cites W3043619128 @default.
• W4311598033 cites W3046152640 @default.
• W4311598033 cites W3087296748 @default.
• W4311598033 cites W3106704421 @default.
• W4311598033 cites W3127051356 @default.
• W4311598033 cites W3137476328 @default.
• W4311598033 cites W3159501890 @default.
• W4311598033 cites W3170965404 @default.
• W4311598033 cites W3173690821 @default.
• W4311598033 cites W3194618061 @default.
• W4311598033 cites W4210589143 @default.
• W4311598033 cites W4281485043 @default.
• W4311598033 cites W4284881226 @default.
• W4311598033 doi "https://doi.org/10.1136/jitc-2022-005769" @default.
• W4311598033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36521929" @default.
• W4311598033 hasPublicationYear "2022" @default.
• W4311598033 type Work @default.
• W4311598033 citedByCount "5" @default.
• W4311598033 countsByYear W43115980332023 @default.
• W4311598033 crossrefType "journal-article" @default.
• W4311598033 hasAuthorship W4311598033A5001994677 @default.
• W4311598033 hasAuthorship W4311598033A5003952746 @default.
• W4311598033 hasAuthorship W4311598033A5014284237 @default.
• W4311598033 hasAuthorship W4311598033A5023853520 @default.
• W4311598033 hasAuthorship W4311598033A5023930172 @default.
• W4311598033 hasAuthorship W4311598033A5043622943 @default.
• W4311598033 hasAuthorship W4311598033A5043634025 @default.
• W4311598033 hasAuthorship W4311598033A5051567139 @default.
• W4311598033 hasAuthorship W4311598033A5077153113 @default.
• W4311598033 hasBestOaLocation W43115980331 @default.
• W4311598033 hasConcept C121608353 @default.
• W4311598033 hasConcept C129374314 @default.
• W4311598033 hasConcept C149532602 @default.
• W4311598033 hasConcept C154317977 @default.
• W4311598033 hasConcept C179185449 @default.
• W4311598033 hasConcept C202751555 @default.
• W4311598033 hasConcept C203014093 @default.
• W4311598033 hasConcept C2776090121 @default.
• W4311598033 hasConcept C2777701055 @default.
• W4311598033 hasConcept C2778867473 @default.
• W4311598033 hasConcept C2780674031 @default.
• W4311598033 hasConcept C502942594 @default.
• W4311598033 hasConcept C54355233 @default.
• W4311598033 hasConcept C55493867 @default.
• W4311598033 hasConcept C55721878 @default.
• W4311598033 hasConcept C86803240 @default.

• next